This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A New Sheen Retinal Dystrophy

Timothy D. Polk, MD; J. Donald M. Gass, MD; W. Richard Green, MD; Michael A. Novak, MD; Mark W. Johnson, MD

Arch Ophthalmol. 1997;115(7):878-885.

Abstract
Objective
To describe the clinicopathologic features of a previously unreported retinal dystrophy.

Methods
Fourteen members of a single family were examined. The medical records of 2 additional family members were reviewed. Pathologic examination was performed on 2 eyes of 1 affected patient.

Results
Five individuals were identified with a retinal dystrophy characterized by a glistening inner retinal surface throughout the posterior pole. Visual loss occurred in 3 affected patients in later life owing to superficial polycystic retinal edema and retinal folds. Electroretinographic testing revealed a selective diminution of the b wave. Pathologic examination revealed an abnormal internal limiting membrane with schisis cavities in the inner retina. Endothelial cell swelling, pericyte degeneration, and basement membrane thickening were present in retinal capillaries.

Conclusions
A previously unreported sheen retinal dystrophy is described. Pedigree analysis suggests an autosomal dominant mode of inheritance. A primary defect in Müller cells is the suspected, but unproved, cause. No effective treatment for the associated visual loss is known. The term familial internal limiting membrane dystrophy is proposed to describe this condition.

Author Affiliations
From the Bascom Palmer Eye Institute, University of Miami School of Medicine, Fla (Drs Polk and Gass); the Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Green); the Retina Associates of Cleveland, Cleveland, Ohio (Dr Novak); and the W. K. Kellogg Eye Center, University of Michigan School of Medicine, Ann Arbor, (Dr Johnson). Dr Polk is now affiliated with The Retina Center, Baltimore, Md.; Dr Gass is now affiliated with the Vanderbilt University School of Medicine, Nashville, Tenn.

Footnotes
The authors have no proprietary interest in any of the products discussed in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A New Macular Dystrophy With Anomalous Vascular Development, Pigment Spots, Cystic Spaces, and Neovascularization
Mahajan et al.
Arch Ophthalmol 2009;127:1449-1457.
ABSTRACT | FULL TEXT  

Focal Macular ERGs in Eyes after Removal of Macular ILM during Macular Hole Surgery
Terasaki et al.
IOVS 2001;42:229-234.
ABSTRACT | FULL TEXT  

Characterization of the intermolecular associations of the dystrophin-associated glycoprotein complex in retinal Muller glial cells
Claudepierre et al.
J. Cell Sci. 2000;113:3409-3417.
ABSTRACT  

Electrophysiological evaluation of visual loss in Muller cell sheen dystrophy
Kellner et al.
Br J Ophthalmol 1998;82:650-654.
ABSTRACT | FULL TEXT